Entelexo Biotherapeutics Inc. — Form C/A (Regulation Crowdfunding)
Entelexo Biotherapeutics Inc. of Irvine, CA filed a Form C/A (Regulation Crowdfunding) with the SEC on 2021-07-02. Target raise $20K, up to $1.1M. Offered through Wefunder Portal LLC.
Offering
- Filed: 2021-07-02
- Form: C/A
- Accession: 0001670254-21-000769
- Target amount: $20K
- Maximum amount: $1.1M
- Security type: Other
- Securities offered: 20,000
- Price: $1.0000
- Deadline: 2022-04-30
- Funding portal / intermediary: Wefunder Portal LLC
- Intermediary file number: 007-00033
- Intermediary CRD: 283503
Issuer
- CIK: 0001867546
- Website: http://Entelexo.com
- Legal status: Corporation
- Organized in: DE
- Incorporated: 2020-04-22
- Address: 5270 California Ave Ste 300, Irvine, CA, 92617
- Employees: 3
Financials (as filed)
- Total assets (most recent): $357K
- Cash (most recent): $306K
- Net income (most recent): $-71K
People (3)
| Name | Role | Location |
|---|
| Charles Cameron Taylor | CTO | Irvine, CA |
| Milad Riazifar | CEO | Irvine, CA |
| Todd Schurr | COO | Irvine, CA |
Reg CF filing history (2)
More